Summit Therapeutics Inc. Deferred Income Tax Liabilities, Net
Summit Therapeutics Inc. (SMMT) had Deferred Income Tax Liabilities, Net of $2.11 million as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2020-11-16
- 2020-09-30: Deferred Income Tax Liabilities, Net $2.11M.
- 2020-06-30: Deferred Income Tax Liabilities, Net $2.06M.
- 2019-12-31: Deferred Income Tax Liabilities, Net $2.06M.
- 2019-01-31: Deferred Income Tax Liabilities, Net $2.20M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2020-09-30 | $2.11M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.06M 8-K · filed 2020-09-29 |
| 2019-12-31 | $2.06M 10-Q · filed 2020-11-16 |
| 2019-01-31 | $2.20M 8-K · filed 2020-09-29 |
| 2018-01-31 | $3.37M 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |